CN109528518A - A kind of face cream and preparation method thereof - Google Patents
A kind of face cream and preparation method thereof Download PDFInfo
- Publication number
- CN109528518A CN109528518A CN201811572806.2A CN201811572806A CN109528518A CN 109528518 A CN109528518 A CN 109528518A CN 201811572806 A CN201811572806 A CN 201811572806A CN 109528518 A CN109528518 A CN 109528518A
- Authority
- CN
- China
- Prior art keywords
- parts
- face cream
- mixed solution
- skin
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000006071 cream Substances 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- -1 syringic acid matrine salt Chemical class 0.000 claims abstract description 41
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N Syringic acid Natural products COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000002562 thickening agent Substances 0.000 claims abstract description 22
- 150000004702 methyl esters Chemical class 0.000 claims abstract description 21
- 239000008367 deionised water Substances 0.000 claims abstract description 19
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 19
- 239000003974 emollient agent Substances 0.000 claims abstract description 12
- 239000004909 Moisturizer Substances 0.000 claims abstract description 9
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 9
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 9
- 230000001333 moisturizer Effects 0.000 claims abstract description 9
- 239000011259 mixed solution Substances 0.000 claims description 49
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 25
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 22
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims description 22
- 125000005456 glyceride group Chemical group 0.000 claims description 21
- 235000013311 vegetables Nutrition 0.000 claims description 21
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 18
- 229940086555 cyclomethicone Drugs 0.000 claims description 18
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 17
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 17
- 229920002674 hyaluronan Polymers 0.000 claims description 17
- 229940057910 shea butter Drugs 0.000 claims description 17
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 15
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 15
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical class C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 8
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 150000001447 alkali salts Chemical class 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 241000251778 Squalus acanthias Species 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 12
- 230000003020 moisturizing effect Effects 0.000 abstract description 12
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 10
- 239000002253 acid Substances 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 206010013786 Dry skin Diseases 0.000 abstract description 4
- 230000003266 anti-allergic effect Effects 0.000 abstract description 4
- 230000037336 dry skin Effects 0.000 abstract description 4
- 230000004224 protection Effects 0.000 abstract description 4
- 238000009736 wetting Methods 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 51
- 230000000694 effects Effects 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 16
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 9
- 238000007599 discharging Methods 0.000 description 8
- 238000007689 inspection Methods 0.000 description 8
- 229930014456 matrine Natural products 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 238000013019 agitation Methods 0.000 description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000011265 semifinished product Substances 0.000 description 5
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- GHBFNMLVSPCDGN-UHFFFAOYSA-N caprylic acid monoglyceride Natural products CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 229930015582 oxymatrine Natural products 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 238000002242 deionisation method Methods 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 235000006793 Artemisia stelleriana Nutrition 0.000 description 2
- 244000252230 Artemisia stelleriana Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000544061 Cuculus canorus Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- ZSBXGIUJOOQZMP-BHPKHCPMSA-N sophoridine Chemical compound C1CC[C@@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-BHPKHCPMSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- GOLXRNDWAUTYKT-UHFFFAOYSA-N 3-(1H-indol-3-yl)propanoic acid Chemical group C1=CC=C2C(CCC(=O)O)=CNC2=C1 GOLXRNDWAUTYKT-UHFFFAOYSA-N 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000074881 Conyza canadensis Species 0.000 description 1
- 235000004385 Conyza canadensis Nutrition 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241001453894 Lindsaeaceae Species 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 241000186362 Mycobacterium leprae Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001531309 Quercus infectoria Species 0.000 description 1
- 241000208422 Rhododendron Species 0.000 description 1
- 241000681946 Rhododendron dauricum Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- AAGFPTSOPGCENQ-UHFFFAOYSA-N Sophocarpin I Natural products C1CCC2CN3C(=O)C=CCC3C3C2N1CCC3 AAGFPTSOPGCENQ-UHFFFAOYSA-N 0.000 description 1
- IGXQFUGORDJEST-UHFFFAOYSA-N Sophocarpine Natural products O=C1C=CCC2C3CCCC4CCCC(CN12)C34 IGXQFUGORDJEST-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000036576 dermal application Effects 0.000 description 1
- BCAARMUWIRURQS-UHFFFAOYSA-N dicalcium;oxocalcium;silicate Chemical compound [Ca+2].[Ca+2].[Ca]=O.[O-][Si]([O-])([O-])[O-] BCAARMUWIRURQS-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical group C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QMGGMESMCJCABO-UHFFFAOYSA-N n-oxysophocarpine Chemical compound C12C3CCC[N+]2([O-])CCCC1CN1C3CC=CC1=O QMGGMESMCJCABO-UHFFFAOYSA-N 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- LJPZHJUSICYOIX-UHFFFAOYSA-N quinolizidine Chemical class C1CCCC2CCCCN21 LJPZHJUSICYOIX-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- AAGFPTSOPGCENQ-JLNYLFASSA-N sophocarpine Chemical compound C1CC[C@H]2CN3C(=O)C=CC[C@@H]3[C@@H]3[C@H]2N1CCC3 AAGFPTSOPGCENQ-JLNYLFASSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The present invention discloses a kind of face cream and preparation method thereof, wherein face cream includes: 70-80 parts of deionized water by weight, 2-5 parts of thickener 305,6-10 parts of moisturizer, 6-18 parts of emollient, 0.1-0.15 parts of methyl esters, 2-5 parts of VE and 0.05-0.2 parts of syringic acid matrine salt.Face cream provided by the invention is used as functional component using syringic acid matrine salt, and the dissolubility of syringic acid matrine salt enhances 3 orders of magnitude than cloves solubility in acid, can be good at locking moisture of skin, avoids skin water loss and the dry skin that causes；And syringic acid matrine salt, as natural ion salt, thermal stability reaches 150 DEG C, has inoxidizability and anti-inflammatory bactericidal properties, can enhance the wetting and protection to skin.Therefore, face cream provided by the invention has permanent moisturizing and has both anti-oxidant anti-inflammatory antiallergic effect.
Description
Technical field
The present invention relates to skin care fields more particularly to a kind of face cream and preparation method thereof.
Background technique
Face cream provides dual anti-aging effect, can stimulate cell neogenesis energy, while promoting collagen synthesis, improves flesh
The texture and the colour of skin uniformity on skin surface layer, keep skin more careful.Containing simultaneously can provide the filter system of SPF15 and can protect flesh
The Moringa essence of skin Antagonistic Environment pollution, keeps the direct injury of skin not light.Face cream is the most important step of basic skin care,
The effective components such as the whitening and anti-aging in face cream can be preferably by percutaneous absorption.According to effect, it is big that face cream is broadly divided into three
Class: moisturizing face cream, whitening cream and anti-aging face cream.The aqueous degree of moisturizing face cream is high, is easy to push away uniform and rapid osmotic to skin
Skin epidermis is easy to be absorbed water conservation degree height；The ingredient of skin care can be allowed to be easy to be persisted, it is not easy to be evaporated, tie up
The certain water content for holding skin, allows skin non-greasy, and oil content is few, and there are also oil-control effects.Whitening cream component requirements safety,
It does not stimulate, not spirituosity, mild, and moistening effect will be got well；Especially whitening composition is oxidized easily, therefore it is steady to improve system
It is qualitative necessary.Anti-aging face cream requires moistening effect to get well, because of the good suction that could promote aging ingredient of moistening effect
It receives；And moisturizing effect will be got well, and start the skin of aging other than moisture content is insufficient, and oil also starts to reduce, and sufficiently moistens
It can prevent wrinkle from generating；Aging ingredient mainly has Alphalin, and collagen wins peptide and Q10 etc..Creme is denseer journey
Paste body shape, generally there is oil-containing rouge relatively small number of, mainly combination, neutral skin use；Another kind is that have to grow
Moisten ingredient, stemness and sensitive skin is suitble to use.Also one is the face creams for repairing face, it is generally in creme state, no
Same is that it is added to cosmetic ingredient (being commonly called as foundation cream) more, coats the effect of opposite modification complexion and covering mark.
Face cream is an important link in skin nursing, and face cream in the market is dazzling, and some face creams have skin
Sliminess, the too strong and thick and heavy essence of fragrance causes skin not moist enough and salubrious；Some face creams, which contain, causes acne risk
Emulsifier allows skin to become sensitive flesh；Face cream persistence also is not grown, and needs frequently to wipe face cream reagent；In addition, existing face
The inoxidizability and anti-inflammatory bactericidal property of frost are poor.
Therefore, the existing technology needs to be improved and developed.
Summary of the invention
In view of above-mentioned deficiencies of the prior art, the purpose of the present invention is to provide a kind of face creams and preparation method thereof, it is intended to
Solve the problems, such as that existing face cream Product Safety difference and inoxidizability on the market and anti-inflammatory bactericidal property are poor.
Technical scheme is as follows:
A kind of face cream, wherein it by weight include: 70-80 parts of deionized water, 2-5 parts of thickener 305,6-10 parts
Moisturizer, 6-18 parts of emollient, 0.1-0.15 parts of methyl esters, 2-5 parts of VE and 0.05-0.2 parts of syringic acid matrine
Salt.
The face cream, wherein the moisturizer includes: 0.05-0.1 parts of many mountain hyaluronic acids, 5- by weight
The A631 of 8 parts of vegetable glycerides and 0.5-1 part.
The face cream, wherein the emollient includes 1-3 parts of cyclomethicone, 1-3 parts of poly dimethyl
Siloxanes, 1-3 parts of ethylhexyl palmitate, 1-3 parts of saualane, 1-3 parts of caprylic/capric triglyceride and 1-3 part
Shea butter.
The face cream, wherein it by weight include: 74-78 parts of deionized water, 2-3 parts of thickener 305,
0.05-0.08 parts of many mountain hyaluronic acids, 5-7 parts of vegetable glycerides, 0.5-0.8 parts of A631,1-3 parts of ring poly dimethyl
Siloxanes, 1-3 parts of dimethyl silicone polymer, 1-3 parts of ethylhexyl palmitate, 1-3 parts of saualane, 1-3 parts of octanoic acid/
Triglyceride DDD, 1-3 parts of shea butter, 0.1-0.15 parts of methyl esters, 2-4 parts of VE and 0.05-0.2 parts of syringic acid
Matrine salt.
The face cream, wherein it by weight include: 75.82 parts of deionized water, 2.5 parts of thickener 305,
0.06 part of many mountain hyaluronic acids, 6 parts of vegetable glycerides, 0.6 part of A631,2 parts of cyclomethicone, 2 parts poly-
Dimethyl siloxane, 2 parts of ethylhexyl palmitate, 2 parts of saualane, 23 parts of caprylic/capric triglyceride, 1.8 parts
Shea butter, 0.12 part of methyl esters, 3 parts of VE and 0.1 part of syringic acid matrine salt.
A kind of preparation method of face cream, wherein comprising steps of
Deionized water, many mountains hyaluronic acids, vegetable glycerides, methyl esters are added in the first emulsion pot, are uniformly mixed that obtain first mixed
Solution is closed, the mixed solution is heated to the first temperature, homogeneous 3-5min, insulated and stirred 10-30min；
By cyclomethicone, dimethyl silicone polymer, ethylhexyl palmitate, saualane, caprylic/capric triglyceride
And VE is added in the second emulsion pot, and second temperature is heated in mixed process, obtains the second mixed solution；
Second mixed solution is added in the first mixed solution, third temperature is cooled to, is then added in whipping process
Enter thickener 305, obtains third mixed solution；
By the third miscible fluid greenhouse cooling to the 4th temperature, A631 then is added into third mixed solution and cloves is bitter
Join alkali salt, stirs evenly, obtain the face cream.
The preparation method of the face cream, wherein first temperature is 80-100 DEG C.
The preparation method of the face cream, wherein the second temperature is 80-90 DEG C.
The preparation method of the face cream, wherein the third temperature is 50-70 DEG C.
The preparation method of the face cream, wherein the described 4th 40-50 DEG C of temperature.
The utility model has the advantages that the present invention makees moisturizer with deionization water as solvent, with vegetable glycerides, many mountains hyaluronic acid, A631,
Make preservative with methyl esters, with cyclomethicone, dimethyl silicone polymer, ethylhexyl palmitate, saualane, octanoic acid/
Triglyceride DDD and shea butter make emollient, make skin conditioning agent with VE, using syringic acid matrine salt as effect at
Not only ingredient is scientific and reasonable for face cream made from point, but also ingredient is safe and reliable；And the present invention is made using syringic acid matrine salt
Dissolubility for functional component, the syringic acid matrine salt enhances about 3 orders of magnitude than cloves solubility in acid, can be fine
Locking moisture of skin, avoid skin water loss and the dry skin that causes；And syringic acid matrine salt as naturally from
Alite, thermal stability reach 150 DEG C, have inoxidizability and anti-inflammatory bactericidal properties, can enhance the wetting and protection to skin.Cause
This, face cream security performance provided by the invention is high, and has permanent moisturizing and have both anti-oxidant anti-inflammatory antiallergic effect.
Detailed description of the invention
Fig. 1 is a kind of flow chart of the preparation method preferred embodiment of face cream of the present invention.
Specific embodiment
The present invention provides a kind of face creams and preparation method thereof, to make the purpose of the present invention, technical solution and effect more
Clear, clear, the present invention is described in more detail below.It should be appreciated that specific embodiment described herein is only to solve
The present invention is released, is not intended to limit the present invention.
The present invention provides a kind of face cream, by weight includes 70-80 parts of deionized water, 2-5 parts of thickener
305,6-10 parts of moisturizer, 6-18 parts of emollient, 0.1-0.15 parts of methyl esters, VE and 0.05-0.2 parts of 2-5 parts
Syringic acid matrine salt.
In the present embodiment, the syringic acid matrine salt is one generated by syringic acid and matrine by neutralization reaction
The natural ion salt of kind.Wherein, the syringic acid can be planted from compositae plant knitting wool careless (Artemisia stelleriana, Horseweed Herb), overground part Ericaceae
Object rhododendron dauricum, leaf korean rhododendron, Ye Baihua cuckoo, Ye little Hua cuckoo, leaf umbelliferae fennel, leaf Lindsaeaceae plant crow
It extracts and obtains in the goitre of fern, leaf malvaceae plant Althaea officinalis and leaf Fagaceae gall oak, syringic acid has stronger anti-
Oxidation and antibacterial action are the main antibiotic effective ingredient of Artemisia stelleriana, there is antibacterium and fungi；The matrine is by pulse family
A kind of alkaloid that root, stem, the fruit of plant kuh-seng are extracted through organic solvents such as ethyl alcohol, belongs to the derivative of quinolizidine kind
Lupin alkaloids.Kuh-seng ingredient mainly has matrine, oxymatrine, sophocarpine, N-Oxysophocarpine, Sophoridine etc. a variety of
Alkaloid, with the content highest of matrine, oxymatrine.Matrine have antibacterial, relieving asthma, a variety of pharmacology such as increasing leucocyte are made
With.Animal experiments show that having inhibiting effect to certain malignant tumours, oxymatrine is especially prominent, chemotherapeutic index be rely on oneself it is mould
7.8 times of element.The lethal effect of LA-795 cell is remarkably reinforced under anoxia state.0.3%~1% kuh-seng aqueous slkali is to B-mode
Streptococcus, shigella dysenteriae, proteus, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa all have a strong inhibitory effect,
7.5%~10% oxymatrine also has inhibiting effect to dysentery, Escherichia coli, Staphylococcus aureus, beta streptococcus.Separately
Have been reported that Banlangen to pathogen such as tubercle bacillus, comma bacillus, Mycobacterium leprae, skin pathogenicity fungi and Leptospira
Also there is certain inhibition killing effect.And matrine realizes antibiotic-free in terms of skin care and the new of the safe anti-acne of hormone is dashed forward
It is broken.Matrine, which contains natural component, dispels acne agent, and it is parasitic to kill the face such as the propionibacterium acnes for being led to acne, acarid rapidly
Flora, safety is good, quickly effective.
The present embodiment uses the effect of syringic acid matrine salt is as face cream ingredient, the dissolution of the syringic acid matrine salt
Property than cloves solubility in acid enhance about 3 orders of magnitude, can be good at lock moisture of skin, avoid skin water loss and draw
The dry skin of hair；And syringic acid matrine salt, as natural ion salt, thermal stability reaches 150 degrees Celsius, has anti-
Oxidisability and anti-inflammatory bactericidal properties can enhance wetting and protection to skin.Further, due in composition syringic acid matrine salt
Matrine and syringic acid both from extracted form natural plant, security performance is high, can be as function important in face cream formula
Imitate ingredient.
In a preferred embodiment, the thickener 305 mainly includes polyacrylamide and the different alkane of C13-14
Hydrocarbon.The thickener 305 has the advantages that swelling is fireballing, can be made into gel in moment, be it is a kind of at normal temperature and high temperature
Under all can produce the new materials of creams without neutralizing, various greases can be emulsified, without considering its HLB value, it can with it is other
Conventional emulsifier compounding is used alone, and is used to prepare the products such as various skin care creams, white adornment gel, the creams as made from it,
Appearance is glossy, and sense of touch is splendid, soft and smooth.
In a preferred embodiment, the moisturizer includes: that 0.05-0.1 parts of many mountains are transparent by weight
Matter acid, the A631 of 5-8 parts of vegetable glycerides and 0.5-1 part.Wherein, the A631 is colourless or light yellow clear clarified solution
Body has moisturizing and bacteriostasis.Specifically, the A631 includes glycerol caprylate, decoyl hydroximic acid and 1,2- penta 2
Alcohol, main antipathogenic composition are glycerol caprylate and decoyl hydroximic acid, have preferable inhibitory effect to bacterium, fungi；It is described
1,2- pentanediol can be obviously improved whole bacteriostasis as antibacterial synergistic component, while have certain moistening effect.
Preferably, the present embodiment can cooperate with using A631 and syringic acid matrine salt as ingredient the effect of face cream and play it
Fungistatic effect improves the whole bacteriostasis of face cream.
In a preferred embodiment, the emollient includes 1-3 parts of cyclomethicone, 1-3 parts
Dimethyl silicone polymer, 1-3 parts of ethylhexyl palmitate, 1-3 parts of saualane, 1-3 parts of caprylic/capric triglyceride with
And 1-3 parts of shea butter.Wherein, the caprylic/capric triglyceride is that height clearly spends tasteless grease, belongs to palm oil or coconut palm
It is extracted using hot fractional method to the derivative of seed oil, since it has compatible feature with human skin, so very suitable
It closes Oily to use, and pore will not be blocked, it has non-greasy texture, it can be improved in creams or lotion by, which being added, prolongs
Stretching property has lubrication and makes the effect of skin softness, and had the function of filtering ultraviolet；Wherein, the cyclomethicone
It is made of a variety of cyclic polyorganosiloxane mixtures, can there is very high intermiscibility with many cosmetics components, texture is slim and graceful,
Clearly, non-greasy can improve formula, improve sense of touch, and remain without permanence, be the common desirable feedstock of cosmetic formulations；Its
In, the ethylhexyl palmitate permeability is good, tool antiperspirant acts on, is strong with skin affinity, for the ventilative oil of stemness, is widely applied
It is excellent skin emollient in skin care item and cosmetics, performance is stablized, and not oxidizable or generation peculiar smell can make skin
It is soft soft and without greasy feeling, good penetrability；Wherein, the saualane is a kind of lipid closest to human sebaceous, affinity
By force, maintenance epidermis can be reinforced, be effectively formed natural protective film, help the balance between skin and sebum, additionally it is possible to inhibit skin rouge
The peroxidating of matter can effectively infiltrate through skin, and promote the proliferation of skin base cell, to delay skin aging, improve and disappear
Except chloasma has apparent physiologic effect, the saualane can also be such that skin pore opens, and promote blood microcirculation, promote thin
Damaged cell is repaired in the metabolism of born of the same parents, help；Wherein, the phytosterol contained by the shea butter (Phytosterols)
And the non-saponified ingredient such as vitamin E, it can abundant moisturizing, moreover it is possible to ultraviolet light (UVB) is resisted, in addition, these ingredients also have
The function of splendid maintenance, anti-inflammatory；Shea butter has the function of good Cutaneous permeation, can promote skin keratin confluent monolayer cells
It is rehydrated, while can skin surface formed protecting film, prevent moisture of skin from volatilizing, thus to skin have potent moisturizing
Effect, inherently a kind of natural emollient of shea butter, while playing the role of Exfoliating Scrub, preventing skin aging, thus cream
The wooden fruit oil is the good additive of skin whitener, nutrition anti-aging cream again.
The present embodiment by it is a variety of with moisturizing, UV resistance, promote cell metabolism ingredient with a kind of preferred ratio
The emollient as face cream is mixed, the effect for playing its respectively can be cooperateed with, obtain excellent skin effect.
In a preferred embodiment, the present embodiment is using VE(vitamin E) as the skin conditioning agent of face cream, it is described
Vitamin E itself is a kind of good antioxidant, it, which can enter Skin Cell, has free radical resisting chain reaction, from theory
It is upper to be better than superoxide dismutase (SOD), in dermal application in prevention keratinization, the rehabilitation burnt can be accelerated, prevent skin from staying
Lower scar.
In a preferred embodiment, the face cream includes: 74-78 parts of deionized water by weight, and 2-3 parts
Thickener 305,0.05-0.08 parts of many mountain hyaluronic acids, 5-7 parts of vegetable glycerides, 0.5-0.8 parts of A631,1-3 part
Cyclomethicone, 1-3 parts of dimethyl silicone polymer, 1-3 parts of ethylhexyl palmitate, 1-3 parts of saualane,
1-3 parts of caprylic/capric triglyceride, 1-3 parts of shea butter, 0.1-0.15 parts of methyl esters, 2-4 parts of VE and 0.05-
0.2 part of syringic acid matrine salt.
In a kind of preferred embodiment, the face cream includes: 75.82 parts of deionized water by weight, and 2.5
305,0.06 part of thickener of many mountain hyaluronic acids of part, 6 parts of vegetable glycerides, 0.6 part of A631,2 parts of ring poly dimethyl
Siloxanes, 2 parts of dimethyl silicone polymer, 2 parts of ethylhexyl palmitate, 2 parts of saualane, 23 parts of caprylic/capric are sweet
Oily three esters, 1.8 parts of shea butter, 0.12 part of methyl esters, 3 parts of VE and 0.1 part of syringic acid matrine salt.
Specifically, the present invention makees moisturizer with deionization water as solvent with vegetable glycerides, many mountains hyaluronic acid, A631,
Make preservative with methyl esters, with cyclomethicone, dimethyl silicone polymer, ethylhexyl palmitate, saualane, octanoic acid/
Triglyceride DDD and shea butter make emollient, make skin conditioning agent with VE, using syringic acid matrine salt as effect at
Not only ingredient is scientific and reasonable for face cream made from point, but also ingredient is safe and reliable；And face cream obtained has permanent moisturizing and has both
Anti-oxidant anti-inflammatory antiallergic effect.
Further, the present invention also provides a kind of preparation methods of face cream, wherein as shown in Figure 1, comprising steps of
S10, deionized water, many mountains hyaluronic acids, vegetable glycerides, methyl esters are added in the first emulsion pot, are uniformly mixed and obtain the
The mixed solution is heated to the first temperature, homogeneous 3-5min, insulated and stirred 10-30min by one mixed solution；
S20, by cyclomethicone, dimethyl silicone polymer, ethylhexyl palmitate, saualane, caprylic/capric glycerol
Three esters and VE are added in the second emulsion pot, and second temperature is heated in mixed process, obtains the second mixed solution；
S30, second mixed solution is added in the first mixed solution, third temperature is cooled to, then in whipping process
Middle addition thickener 305, obtains third mixed solution；
S40, by the third miscible fluid greenhouse cooling to the 4th temperature, A631 and cloves are then added into third mixed solution
Sour matrine salt, stirs evenly, and obtains the face cream.
Specifically, cleaning and sterilizing is carried out to emulsion pot using pure hot water first, then weighs deionization in proportion
Water, many mountains hyaluronic acid, vegetable glycerides, methyl esters are simultaneously added in the emulsion pot, are uniformly dispersed to obtain under high speed agitation
First mixed solution；Then first mixed solution is heated to 80-100 DEG C under agitation, and with 3000-
The revolving speed homogeneous 3-5min of 4000rpm, later insulated and stirred 10-30min；By cyclomethicone, polydimethylsiloxanes
Alkane, ethylhexyl palmitate, saualane, caprylic/capric triglyceride and VE are added in another emulsion pot, in mixed process
It is heated to 80-90 DEG C, obtains the second mixed solution；Second mixed solution is added in the first mixed solution, is cooled to
50-70 DEG C, thickener 305 is then added in whipping process, obtains third mixed solution；The third miscible fluid temperature is dropped
Then A631 and syringic acid matrine salt is added to 40-50 DEG C in temperature into third mixed solution, continue to stop after stirring 10-30min
It only stirs, cooling, then inspection waits discharging；Storage vat is sealed after discharging, and is moved between standing for use.Semi-finished product are closed through quality inspection
It is dispensed after lattice；Packaging coding obtains finished product face cream, is put in storage.
All contact cosmetics raw and auxiliary materials, the equipment of semi-finished product, apparatus, pipeline are equal during the preparation process for face cream of the invention
It is made of nontoxic, harmless, anti-anticorrosion material, inner wall smooth is without falling off；Production equipment carries out periodic maintenance, maintenance and cleaning,
Production equipment will not introduce security risks substance.
Explanation is further explained to a kind of face cream of the present invention and preparation method thereof below by specific embodiment:
Embodiment 1
A kind of face cream includes: 75 parts of deionized water, 2 parts of 305,0.06 part of thickener of many mountain hyalomitomes by weight
Acid, 5 parts of vegetable glycerides, 0.6 part of A631,1 part of cyclomethicone, 1 part of dimethyl silicone polymer, 1 part
Ethylhexyl palmitate, 1 part of saualane, 1 part of caprylic/capric triglyceride, 1 part of shea butter, 0.1 part of methyl esters, 2
VE and 0.05 part of the syringic acid matrine salt of part.
The preparation method of face cream in embodiment 1, comprising steps of
Deionized water, many mountains hyaluronic acid, vegetable glycerides, methyl esters are weighed based on above-mentioned parts by weight and is added in emulsion pot, in height
It is uniformly dispersed to obtain the first mixed solution under fast stirring condition；Then first mixed solution is heated under agitation
80 DEG C, and with the revolving speed homogeneous 3min of 3000rpm, insulated and stirred 10min later；By cyclomethicone, poly dimethyl
Siloxanes, ethylhexyl palmitate, saualane, caprylic/capric triglyceride and VE are added in another emulsion pot, are mixing
It is heated to 80 DEG C in journey, obtains the second mixed solution；Second mixed solution is added in the first mixed solution, is cooled to
50 DEG C, thickener 305 is then added in whipping process, obtains third mixed solution；By the third miscible fluid greenhouse cooling
To 40 DEG C, A631 and syringic acid matrine salt are then added into third mixed solution, continues to stop stirring after stirring 10min,
Cooling, then inspection waits discharging；Storage vat is sealed after discharging, and is moved between standing for use.Semi-finished product divide after quality inspection is qualified
Dress；Packaging coding obtains finished product face cream, is put in storage.
Embodiment 2
A kind of face cream, includes: 75.82 parts of deionized water by weight, and 2.5 parts of 305,0.06 part of thickener of many mountains are saturating
Bright matter acid, 6 parts of vegetable glycerides, 0.6 part of A631,2 parts of cyclomethicone, 2 parts of dimethyl silicone polymer, 2
The ethylhexyl palmitate of part, 2 parts of saualane, 23 parts of caprylic/capric triglyceride, 1.8 parts of shea butter, 0.12 part
Methyl esters, 3 parts of VE and 0.1 part of syringic acid matrine salt.
The preparation method of face cream in embodiment 2, comprising steps of
Deionized water, many mountains hyaluronic acid, vegetable glycerides, methyl esters are weighed based on above-mentioned parts by weight and are added in the emulsion pot,
It is uniformly dispersed to obtain the first mixed solution under high speed agitation；Then first mixed solution is added under agitation
Heat is to 90 DEG C, and with the revolving speed homogeneous 4min of 3500rpm, insulated and stirred 20min later；By cyclomethicone, poly- two
Methylsiloxane, ethylhexyl palmitate, saualane, caprylic/capric triglyceride and VE are added in another emulsion pot, mixed
85 DEG C are heated to during closing, obtains the second mixed solution；Second mixed solution is added in the first mixed solution, is dropped
Then thickener 305 is added in whipping process, obtains third mixed solution to 60 DEG C for temperature；By the third miscible fluid temperature
45 DEG C are cooled to, A631 and syringic acid matrine salt are then added into third mixed solution, continues to stop stirring after stirring 20min
It mixes, cooling, then inspection waits discharging；Storage vat is sealed after discharging, and is moved between standing for use.Semi-finished product are after quality inspection is qualified
Packing；Packaging coding obtains finished product face cream, is put in storage.
Embodiment 3
A kind of face cream, includes: 78 parts of deionized water by weight, and 3 parts of 305,0.08 part of thickener of many mountains are transparent
Matter acid, 7 parts of vegetable glycerides, 0.8 part of A631,3 parts of cyclomethicone, 3 parts of dimethyl silicone polymer, 3 parts
Ethylhexyl palmitate, 3 parts of saualane, 3 parts of caprylic/capric triglyceride, 3 parts of shea butter, 0.15 part of first
Ester, 4 parts of VE and 0.2 part of syringic acid matrine salt.
The preparation method of face cream in embodiment 3, comprising steps of
Deionized water, many mountains hyaluronic acid, vegetable glycerides, methyl esters are weighed based on above-mentioned parts by weight and are added in the emulsion pot,
It is uniformly dispersed to obtain the first mixed solution under high speed agitation；Then first mixed solution is added under agitation
Heat is to 100 DEG C, and with the revolving speed homogeneous 5min of 4000rpm, insulated and stirred 30min later；By cyclomethicone, poly- two
Methylsiloxane, ethylhexyl palmitate, saualane, caprylic/capric triglyceride and VE are added in another emulsion pot, mixed
90 DEG C are heated to during closing, obtains the second mixed solution；Second mixed solution is added in the first mixed solution, is dropped
Then thickener 305 is added in whipping process, obtains third mixed solution to 70 DEG C for temperature；By the third miscible fluid temperature
50 DEG C are cooled to, A631 and syringic acid matrine salt are then added into third mixed solution, continues to stop stirring after stirring 30min
It mixes, cooling, then inspection waits discharging；Storage vat is sealed after discharging, and is moved between standing for use.Semi-finished product are after quality inspection is qualified
Packing；Packaging coding obtains finished product face cream, is put in storage.
Embodiment 4
Face cleaning effect and to skin improve test
It selects 15-30 years old volunteer 150 and is equally divided into 3 groups of personnel, respectively using face made from embodiment 1- embodiment 3
Frost.Volunteer sooner or later respectively with the primary face cream, continuous observation 3 months, counts daily and records experimental result.As a result such as following table institute
Show:
Wherein, the screening criteria of volunteer: the patient with scytitis, Oily has small pox, with acne, dark sore, Cuo
Sore, pockmark have.
A indicates effective, refers to and is significantly improved to skin problem；
B indicates that effect is unobvious, refers to unobvious to the improvement of above-mentioned patient symptom；
C indicates invalid, and referring to does not improve above-mentioned patient symptom；
It can be seen from above-mentioned experimental result face cream provided by the present invention to the improvement ratio of inflammation skin 92% or more, especially
It is the crowd to 16-25 one full year of life, which is usually teenager, is in puberty, skin is more sensitive, is easy to be infected
Cause inflammation.Again demonstrating face cream of the present invention has the effect of moisturizing, antibacterial, anti-inflammatory.
In conclusion face cream provided by the invention uses syringic acid matrine salt as functional component, the cloves is bitter
The dissolubility for joining alkali salt enhances about 3 orders of magnitude than cloves solubility in acid, can be good at locking moisture of skin, avoids skin
Water loss and the dry skin caused；And syringic acid matrine salt, as natural ion salt, thermal stability reaches 150 and takes the photograph
Family name's degree has inoxidizability and anti-inflammatory bactericidal properties, can enhance the wetting and protection to skin.Therefore, face cream provided by the invention
With permanent moisturizing and have both anti-oxidant anti-inflammatory antiallergic effect.
It should be understood that the application of the present invention is not limited to the above for those of ordinary skills can
With improvement or transformation based on the above description, all these modifications and variations all should belong to the guarantor of appended claims of the present invention
Protect range.
Claims (10)
1. a kind of face cream, which is characterized in that it by weight include: 70-80 parts of deionized water, 2-5 parts of thickener 305,
6-10 parts of moisturizer, 6-18 parts of emollient, 0.1-0.15 parts of methyl esters, 2-5 parts of VE and 0.05-0.2 parts of cloves
Sour matrine salt.
2. face cream according to claim 1, which is characterized in that the moisturizer includes: 0.05-0.1 parts by weight
Many mountain hyaluronic acids, the A631 of 5-8 parts of vegetable glycerides and 0.5-1 part.
3. face cream according to claim 2, which is characterized in that the emollient includes 1-3 parts of ring polydimethylsiloxanes
Alkane, 1-3 parts of dimethyl silicone polymer, 1-3 parts of ethylhexyl palmitate, 1-3 parts of saualane, 1-3 parts of caprylic/capric
Triglycerides and 1-3 parts of shea butter.
4. face cream according to claim 3, which is characterized in that by weight include: 74-78 parts of deionized water, 2-3
The thickener 305 of part, 0.05-0.08 parts of many mountain hyaluronic acids, 5-7 parts of vegetable glycerides, 0.5-0.8 parts of A631,1-3
The cyclomethicone of part, 1-3 parts of dimethyl silicone polymer, 1-3 parts of ethylhexyl palmitate, 1-3 parts of spiny dogfish
Alkane, 1-3 parts of caprylic/capric triglyceride, 1-3 parts of shea butter, 0.1-0.15 parts of methyl esters, 2-4 parts of VE and
0.05-0.2 parts of syringic acid matrine salt.
5. face cream according to claim 4, which is characterized in that it by weight include: 75.82 parts of deionized water, 2.5
305,0.06 part of thickener of many mountain hyaluronic acids of part, 6 parts of vegetable glycerides, 0.6 part of A631,2 parts of ring poly dimethyl
Siloxanes, 2 parts of dimethyl silicone polymer, 2 parts of ethylhexyl palmitate, 2 parts of saualane, 23 parts of caprylic/capric are sweet
Oily three esters, 1.8 parts of shea butter, 0.12 part of methyl esters, 3 parts of VE and 0.1 part of syringic acid matrine salt.
6. a kind of preparation method of the face cream as described in claim 3-5 is any, which is characterized in that comprising steps of
Deionized water, many mountains hyaluronic acids, vegetable glycerides, methyl esters are added in the first emulsion pot, are uniformly mixed that obtain first mixed
Solution is closed, the mixed solution is heated to the first temperature, homogeneous 3-5min, insulated and stirred 10-30min；
By cyclomethicone, dimethyl silicone polymer, ethylhexyl palmitate, saualane, caprylic/capric triglyceride
And VE is added in the second emulsion pot, and second temperature is heated in mixed process, obtains the second mixed solution；
Second mixed solution is added in the first mixed solution, third temperature is cooled to, is then added in whipping process
Enter thickener 305, obtains third mixed solution；
By the third miscible fluid greenhouse cooling to the 4th temperature, A631 then is added into third mixed solution and cloves is bitter
Join alkali salt, stirs evenly, obtain the face cream.
7. the preparation method of face cream according to claim 6, which is characterized in that first temperature is 80-100 DEG C.
8. the preparation method of face cream according to claim 6, which is characterized in that the second temperature is 80-90 DEG C.
9. the preparation method of face cream according to claim 6, which is characterized in that the third temperature is 50-70 DEG C.
10. the preparation method of face cream according to claim 6, which is characterized in that the described 4th 40-50 DEG C of temperature.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811572806.2A CN109528518A (en) | 2018-12-21 | 2018-12-21 | A kind of face cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811572806.2A CN109528518A (en) | 2018-12-21 | 2018-12-21 | A kind of face cream and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109528518A true CN109528518A (en) | 2019-03-29 |
Family
ID=65856410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811572806.2A Withdrawn CN109528518A (en) | 2018-12-21 | 2018-12-21 | A kind of face cream and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109528518A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110123653A (en) * | 2019-05-28 | 2019-08-16 | 珠海萱嘉君行健康产业发展有限公司 | A kind of skin care item containing γ-aminobutyric acid matrine ionic liquid |
| CN110151620A (en) * | 2019-05-23 | 2019-08-23 | 珠海萱嘉君行健康产业发展有限公司 | A kind of whitening cream and preparation method thereof containing stachydrine fatty acid ion liquid |
| CN111253401A (en) * | 2020-03-17 | 2020-06-09 | 珠海萱嘉君行健康产业发展有限公司 | Non-steroidal aryl alkanoic acid ionic salt and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105997629A (en) * | 2016-05-24 | 2016-10-12 | 广州南雪药业有限公司 | Acne treatment cream and preparation method thereof |
| CN106619382A (en) * | 2017-01-04 | 2017-05-10 | 广州聚澜健康产业研究院有限公司 | Moisturizing face cream |
| CN108938513A (en) * | 2017-10-25 | 2018-12-07 | 游云利 | A kind of clear skin anti-acne face beautifying cream of quantum and preparation method thereof |
-
2018
- 2018-12-21 CN CN201811572806.2A patent/CN109528518A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105997629A (en) * | 2016-05-24 | 2016-10-12 | 广州南雪药业有限公司 | Acne treatment cream and preparation method thereof |
| CN106619382A (en) * | 2017-01-04 | 2017-05-10 | 广州聚澜健康产业研究院有限公司 | Moisturizing face cream |
| CN108938513A (en) * | 2017-10-25 | 2018-12-07 | 游云利 | A kind of clear skin anti-acne face beautifying cream of quantum and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 吴清等: "《物理药剂学》", 30 November 2018, 中国中医药出版社 * |
| 彭成: "《经产良药益母草》", 30 November 2017, 四川科学技术出版社 * |
| 李欣航等: "无尼泊金酯类化妆品防腐体系的应用研究", 《科技广场》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110151620A (en) * | 2019-05-23 | 2019-08-23 | 珠海萱嘉君行健康产业发展有限公司 | A kind of whitening cream and preparation method thereof containing stachydrine fatty acid ion liquid |
| CN110123653A (en) * | 2019-05-28 | 2019-08-16 | 珠海萱嘉君行健康产业发展有限公司 | A kind of skin care item containing γ-aminobutyric acid matrine ionic liquid |
| CN111253401A (en) * | 2020-03-17 | 2020-06-09 | 珠海萱嘉君行健康产业发展有限公司 | Non-steroidal aryl alkanoic acid ionic salt and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102342993B (en) | Anti-sensitization and restoration external preparation for skin | |
| CN107714539A (en) | Whitening and spot eliminating cream | |
| CN105997580A (en) | Skin-care cleansing oil and preparation method thereof | |
| US20130095196A1 (en) | Blended oil skin moisturizer and skin repairer | |
| CN104983624A (en) | Repairing skin-protecting nourishing mask impregnation liquid and preparation method thereof | |
| CN104027271B (en) | Emulsion and preparation method thereof | |
| CN106619337A (en) | Crowfoot crack resistant cream for infants and a preparing method thereof | |
| CN105902418A (en) | Imitated sebum matrix, external preparation including imitated sebum matrix and application thereof | |
| CN104983647A (en) | Deep restoration mask and making method thereof | |
| CN109248105A (en) | A kind of makeup removing stick and preparation method thereof | |
| CN109528518A (en) | A kind of face cream and preparation method thereof | |
| CN105997620A (en) | Cleansing oil containing Chinese herbal medicine ingredients and preparation method of cleansing oil | |
| CN105411993A (en) | Makeup removing cream and preparation method thereof | |
| CN109330936A (en) | A kind of sun-proof foundation emulsion of anti-aging and preparation method thereof | |
| KR101498609B1 (en) | Manufacturing method of bodylotion using herb and bodylotion made by that manufacturing method | |
| CN105106063A (en) | Folium cortex eucommiae containing whitening massage cream | |
| CN105581948A (en) | Skin surface lipid film repair type makeup removal paste and preparation method thereof | |
| CN115670952A (en) | Oil-control anti-acne composition, skin care product and preparation method | |
| CN106344458A (en) | Whitening cream containing ginseng and cornu cervi pantotrichum | |
| CN109330927A (en) | One kind, which is moistened, repairs plain face frost and preparation method thereof | |
| CN105816393A (en) | Cleansing oil and preparation method thereof | |
| CN101966130A (en) | Silybin nano crystal cosmetics and preparation method thereof | |
| CN111973502A (en) | CC cream for air-permeable cushion and preparation method thereof | |
| CN112472629A (en) | Alpinia officinarum and amomum tsao-ko sun-proof emulsion and preparation method thereof | |
| Bhatnagar et al. | Oils and Fats as Raw Materials for Cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190329 |
|
| WW01 | Invention patent application withdrawn after publication |